Clearway Energy enters the final week of June with an unusual split in its positioning signals: options traders are the most bullish they have been all year, even as short sellers have been gradually adding exposure over the past month.
The options angle is the sharpest read this week. The put/call ratio has collapsed to 0.13, nearly three standard deviations below its 20-day average of 0.21 — the lowest reading of the past year, which bottomed at 0.08. That extreme skew toward calls reflects an unusually lopsided demand for upside exposure relative to the stock's recent norm. It is not a crowded hedge setup; it looks more like a speculative lean toward recovery, with the PCR running well below even typical mild-bullish levels for this name.
Short interest tells a contrasting story. Bears have been quietly rebuilding, with SI up 16% over the past month to roughly 8.1% of the free float — a meaningful level for a contracted renewable utility that tends not to attract heavy directional positioning. The week-on-week move was a further 6% rise, though Tuesday saw a small reversal. Crucially, the borrow market offers no friction to this rebuilding: availability is wide-open at over 620%, meaning roughly six shares are available to borrow for every one already shorted. Cost to borrow is essentially negligible at 0.45%, off about 6% on the week. The short score of 49.9 sits near the middle of the range, ranking in only the 18th percentile for bearishness — so while shorts are accumulating, the lending market is far from stressed.
The Street is skewed constructively but not uniformly. UBS lifted its target to $45 yesterday while maintaining a Buy — the stock closed at $36.56, so that implies roughly 23% upside from current levels. Morgan Stanley has been more aggressive, raising its Overweight target to $60 at the end of May, though that gap to current price is wide enough to warrant note. Most recent analyst moves over the past six months have been in one direction: higher targets, maintained positive ratings. The one neutral voice, Evercore ISI, carries an In-Line rating with a $39 target. Bulls anchor the thesis on Clearway's 7-8% CAFD CAGR guidance through 2030 and the contracted asset base; bears flag CAFD shortfalls, high customer concentration, and policy risk. Valuation is not cheap — PE near 43x, EV/EBITDA at 11.8x — with both multiples having eased modestly over the past 30 days as the stock slid 6% on the month to $36.56.
Institutional flow adds a note of caution. Vanguard trimmed its largest position by roughly 1.96 million shares in the most recent reported period, with a second Vanguard sleeve also cutting. Those are passive-flavoured moves likely reflecting rebalancing rather than conviction, but the aggregate reduction from the largest holder is worth tracking. On the other side, ClearBridge added 547,000 shares, and Neuberger Berman lifted by 300,000 — two active managers moving in opposite directions to the index funds. Insider activity from April has all-sell signatures (CEO, CFO, and General Counsel all sold on April 15 at $40.27), though transaction sizes were small and flagged as low significance.
The next catalyst is Q2 earnings on August 4. Recent prints have been modest negative movers — the stock fell less than 1% on the day after the May print, and 3.4% after the prior quarter. The setup heading into that date is one where options traders are positioned more optimistically than usual, while short sellers have been adding quietly into a declining stock and a loose borrow market. Whether the bullish options tilt reflects genuine conviction or is simply a low-cost call-buying moment after a 6% monthly drop is the question worth watching as August approaches.
See the live data behind this article on ORTEX.
Open CWEN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
